Hae
Aineistot 1-1 / 1
A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer
<p>Metastatic castration resistant prostate
cancer (mCRPC) is one of the most common cancers with a poor prognosis.
To improve prognostic models of mCRPC, the Dialogue for Reverse
Engineering Assessments and Methods ...